CATALYST PHARMACEUTICALS INC

Ticker: CPRX CUSIP: 14888U101 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 13,227 Value ($000) $309 Avg Close $22.28 Range $19.90 - $25.14
Q3 2025
Shares 24,103 Value ($000) $475 Avg Close $20.57 Range $19.05 - $22.53
Q2 2025
Shares 140,823 Value ($000) $3,056 Avg Close $23.61 Range $20.40 - $26.58
Q4 2024
Shares 253,637 Value ($000) $5,293 Avg Close $21.48 Range $19.54 - $24.27
Q3 2024
Shares 860,934 Value ($000) $17,115 Avg Close $18.54 Range $14.97 - $21.67
Q2 2024
Shares 1,219,537 Value ($000) $18,891 Avg Close $15.57 Range $14.47 - $17.03
Q1 2024
Shares 1,683,951 Value ($000) $26,842 Avg Close $15.07 Range $13.12 - $17.50
Q3 2023
Shares 73,991 Value ($000) $865 Avg Close $13.38 Range $11.59 - $15.59
Q2 2023
Shares 194,003 Value ($000) $2,607 Avg Close $14.39 Range $11.09 - $18.22
Q4 2021
Shares 200,308 Value ($000) $1,356 Avg Close $6.58 Range $5.05 - $7.58
Q1 2021
Shares 103,332 Value ($000) $476 Avg Close $3.97 Range $3.27 - $5.05
Q4 2020
Shares 141,798 Value ($000) $474 Avg Close $3.36 Range $2.88 - $3.99
Q3 2020
Shares 296,980 Value ($000) $882 Avg Close $3.91 Range $2.91 - $5.19
Q2 2020
Shares 329,430 Value ($000) $1,522 Avg Close $4.49 Range $3.40 - $5.15
Q1 2020
Shares 1,105,426 Value ($000) $4,256 Avg Close $4.10 Range $2.55 - $5.28
Q4 2019
Shares 1,567,564 Value ($000) $5,878 Avg Close $4.68 Range $3.65 - $5.83